California Public Employees Retirement System
KITE

California Public Employees Retirement System’s Kite Pharma, Inc. KITE Stock Holding History

California Public Employees Retirement System’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,519
Closed -$813K – 3381
2017
Q3 		$813K Sell
4,519
-80,481
-95% -$11.2M ﹤0.01% 2416
2017
Q2 		$8.81M Buy
85,000
+1,800
+2% +$147K 0.01% 902
2017
Q1 		$6.53M Sell
83,200
-3,600
-4% -$223K 0.01% 1090
2016
Q4 		$3.89M Hold
86,800
– – 0.01% 1453
2016
Q3 		$4.85M Sell
86,800
-6,000
-6% -$334K 0.01% 1320
2016
Q2 		$4.64M Sell
92,800
-2,900
-3% -$142K 0.01% 1337
2016
Q1 		$4.39M Buy
95,700
+44,400
+87% +$2.15M 0.01% 1376
2015
Q4 		$3.16M Buy
51,300
+19,000
+59% +$1.34M 0.01% 1617
2015
Q3 		$1.8M Buy
32,300
+12,600
+64% +$793K ﹤0.01% 1987
2015
Q2 		$1.2M Hold
19,700
– – ﹤0.01% 2392
2015
Q1 		$1.47M Hold
19,700
– – ﹤0.01% 2324
2014
Q4 		$1.47M Buy
+19,700
New +$829K ﹤0.01% 2324

California Public Employees Retirement System's KITE Position: Q4 2017 in Review

California Public Employees Retirement System sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 4,519 shares — an estimated $813K sold.

California Public Employees Retirement System first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $8.81M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • California Public Employees Retirement System reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • California Public Employees Retirement System sold 4,519 Kite Pharma, Inc. shares in Q4 2017, an estimated $813K.
  • California Public Employees Retirement System first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • California Public Employees Retirement System's Kite Pharma, Inc. position peaked at $8.81M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on California Public Employees Retirement System's 13F filing for Q4 2017, filed 6 Feb 2018.